Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Henry Schein (HSIC) is navigating a mixed operating environment, with strong growth driven by its Henry Schein One dental software business, which saw mid-single-digit Q3 2024 growth and a 20% customer base expansion, alongside strategic acquisitions and favorable long-term dental industry trends. However, the company faces significant headwinds from the lingering impact of its October 2023 cyber incident, which led to a 2.6% decrease in Q3 internally generated sales, and increasing pricing pressure from Group Purchasing Organizations (GPOs). Despite beating earnings estimates in three of the last four quarters, HSIC's stock has underperformed, falling 4.2% over the past year against substantial industry and S&P 500 growth, reflecting investor concerns over these operational challenges.

Analysis

Henry Schein, Inc. (HSIC) presents a mixed operational and financial profile, characterized by strong growth in its specialized dental software division juxtaposed with significant enterprise-level challenges. The Henry Schein One joint venture is a clear bright spot, demonstrating robust momentum with mid-single-digit growth in core products and a 20% year-over-year expansion of its customer base in Q3 2024. This growth is further supported by an aggressive acquisition strategy, evidenced by the purchases of abc dental AG and TriMed, which expand its geographic reach and product portfolio. However, these positive developments are currently overshadowed by two major headwinds. First, the residual impact of the October 2023 cybersecurity incident continues to depress revenue, contributing to a 2.6% decrease in internally generated local currency sales in the third quarter. Second, the increasing pricing power of Group Purchasing Organizations (GPOs) poses a structural threat to margins across the industry. This bifurcation is reflected in the stock's performance; despite beating earnings estimates in three of the last four quarters, the stock has fallen 4.2% over the past year, starkly underperforming both its industry (+3.7%) and the S&P 500 (+28.6%), signaling that investor concerns over operational risks currently outweigh the company's growth initiatives.

Key Decisions for Investors

• Investors should closely monitor the top-line recovery from the cyberattack, as a failure to recapture sales from episodic customers in subsequent quarters would signal a more permanent erosion of market share.
• The performance of the Henry Schein One division is a primary catalyst; continued double-digit customer base growth and successful adoption of new solutions like Adlumin MDR could justify a long-term position despite near-term headwinds.
• Given the stock's significant underperformance against peers and the market, it is prudent to assess whether the current valuation adequately discounts the persistent margin pressure from GPOs and the ongoing cybersecurity risks before increasing exposure.